<unk>  is a Gastrointestinal Agent that is FDA approved for the treatment of hereditary tyrosinemia type 1 (HT-1).   Common adverse reactions include hepatic neoplasm, liver failure, thrombocytopenia, leucopenia, visual system complaints including conjunctivitis, corneal opacity, keratitis, and photophobia.
Nitisinone
Diiodohydroxyquinoline
Diethylcathinone
Cyclochlorotine
4-Methylmethcathinone
Tetrahydrozoline
Nicotinyl alcohol
Acetarsol